Loading company…
Zymvol uses computational modeling and enzyme engineering to develop enzymes for industrial applications.
Founded in 2017 by Francisco Morís, Simon Sheld, and Juan Pablo Bermúdez, Zymvol specializes in bioinformatics and molecular modeling for enzyme discovery and design. It serves pharmaceutical, chemical, and biotechnology industries with computational design and experimental validation services. Its offerings include In Silico Design and ZymQuest, which help identify and engineer enzymes with desired activity, specificity, and stability. In February 2025, the company raised EUR 3 million in seed funding led by Faber Ventures, with Übermorgen Ventures and Elaia Partners participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in